Guangdong Zhaotai InVivo Biomedicine Co. Ltd. Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2017
NCT03198546
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Guangdong Zhaotai InVivo Biomedicine Co. Ltd.